Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"nutlin-3"”.

  1. Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death

    … satisfactory. In this study, we show that the nutlin-3, a small-molecule inhibitor of murine double minute 2 (MDM2), effectively overcomes the resistance of MDA-MB 435S breast cancer cells to bortezomib. While bortezomib treatment did not markedly alter cellular morphologies, nutlin-3 treatment …

    ajou Repository record for Nutlin-3 sensitizes cancer cells to bortezomib via induction of paraptosis-associated cell death (opens in a new tab)

  2. Hdm2 Small-Molecule Inhibitors For Therapeutic Intervention In B-Cell Lymphoma

    … spiro-oxindoles (MI-219) and cis-imidazoline (Nutlin-3) in lymphoma cell lines and patient-derived B-lymphoma cells. Surprisingly, results revealed significant quantitative and qualitative differences between these two agents. At the molecular level, effect of Nutlin-3 was generally more …

    wayne-thes Repository record for Hdm2 Small-Molecule Inhibitors For Therapeutic Intervention In B-Cell Lymphoma (opens in a new tab)

  3. Regulation of the Insulin-like Growth Factor 1-Secretory Clusterin Expression Axis in Genomic Instability and Cell Stress

    … both p53 and NF-YA bound to the IGF-1 promoter. Nutlin-3, an Mdm2-p53 inhibitor, stabilized p53 expression, leading to dramatically decreased sCLU expression. Nutlin-3 treatment sensitized wild-type p53 cells to IR exposure. Finally, exogenous IGF-1 exposure led to serine 1981 …

    utswmed Repository record for Regulation of the Insulin-like Growth Factor 1-Secretory Clusterin Expression Axis in Genomic Instability and Cell Stress (opens in a new tab)

  4. Investigation of the intrinsic mechanism of drug resistance in multiple myeloma

    … combined with a Mdm2 inhibitor. In p53 WT cells, nutlin-3 in combination with bortezomib generates additive toxicity in MM cells but is highly synergistic in epithelial models and p53-mutated cell lines. This synergy persists in the presence of BMSCs. This observation has implications more so in …

    dcu Repository record for Investigation of the intrinsic mechanism of drug resistance in multiple myeloma (opens in a new tab)